AI Oncology Imaging Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — built from company filings, government statistics and trade data, and structured for confident strategic decision-making. Request a free report preview to see its scope, chapters and methodology before you buy.
Market Snapshot
2025 Market Size
US$ 600.0 million
Estimated Base Value
2035 Forecast
US$ 3.4 billion
Projected Market Value
CAGR 2026–2035
18.9%
Compound Annual Growth
Largest Segment
AI-powered Computer-Aided Detection (CADe)
Fastest Growing Segment
Electric Commercial Vehicles
Leading Region
Asia Pacific
Fastest Growing Region
Asia Pacific
Top Country
United States
By Market Share
Largest market
Key Players
Paige.AI
Emerging Players
Tempus, Vara
AI Oncology Imaging Market Overview
The AI Oncology Imaging Market integrates artificial intelligence into medical imaging for cancer care. This includes AI applications that enhance image acquisition, processing, interpretation, and analysis to improve the detection, diagnosis, staging, prognosis, and treatment planning for various cancers. AI-powered tools assist radiologists and oncologists in identifying abnormalities, segmenting tumors, predicting treatment response, and personalizing patient management. Buyers include hospitals, diagnostic imaging centers, cancer research centers, pharmaceutical and biotechnology companies, academic and research institutes, specialty clinics, and contract research organizations.
The market is estimated at $600.0 Mn in 2025 and is forecast to reach $3.4 Bn in 2035, growing at a CAGR of 18.9% from 2025 to 2035. Demand is driven by the rising global incidence of cancer, which increases the need for early and precise diagnosis. Additionally, radiologist shortages encourage AI adoption to improve efficiency and accuracy. Market growth is held back by stringent regulatory approval processes and challenges in integrating AI solutions into existing clinical workflows.
The market is segmented by Type (AI-Powered Computer-Aided Detection, AI-Powered Computer-Aided Diagnosis, AI-Powered Prognosis and Prediction, AI-Powered Treatment Planning & Response Assessment, AI-Powered Workflow & Image Management, AI-Powered Image Reconstruction & Enhancement, AI-Driven Drug Discovery & Biomarker Identification, AI-Powered Medical Device Integration Software), Technology (Deep Learning, Machine Learning, Natural Language Processing, Computer Vision, Predictive Analytics, Reinforcement Learning, Generative AI), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Cancer, Liver Cancer, Head & Neck Cancer, Other Cancers), End-User (Hospitals, Diagnostic Imaging Centers, Cancer Research Centers, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Specialty Clinics, Contract Research Organizations), Deployment (On-Premise, Cloud-Based, Hybrid, Edge Computing), and Imaging Modality (Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound, X-Ray, Mammography, Digital Pathology, Single-Photon Emission Computed Tomography). Regions covered are Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. Leading companies include Paige.AI, Lunit, Aidoc, PathAI, Ibex Medical Analytics, Qure.ai, Volpara Health Technologies, Nanox Imaging, Elekta, ScreenPoint Medical, Vuno, and Aidence. The full report covers market trends, drivers, restraints, and opportunities.
Market Definition & Overview
The AI Oncology Imaging Market encompasses the advanced integration of artificial intelligence technologies within medical imaging devices and software solutions specifically designed for cancer care. This market focuses on AI applications that enhance the acquisition, processing, interpretation, and analysis of diagnostic images (such as CT, MRI, PET, ultrasound, and mammography) to improve the detection, diagnosis, staging, prognosis, and treatment planning for various cancers. It includes AI-powered tools that aid radiologists and oncologists in identifying subtle abnormalities, segmenting tumors, predicting treatment response, and personalizing patient management, thereby improving diagnostic accuracy and efficiency in oncology workflows.
Scope
- Global coverage across key regions: North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
- Segmentation by imaging modality: CT, MRI, PET, X-ray, Ultrasound, Mammography.
- Segmentation by application: Cancer Detection, Diagnosis, Staging, Treatment Planning, Monitoring.
- Analysis period from the 2025 base year up to a specified forecast horizon (2025-2035).
Inclusions
- AI software platforms for cancer detection in medical images.
- AI algorithms for tumor segmentation and characterization across modalities.
- AI-powered Computer-Aided Detection (CAD) and Diagnosis (CADx) systems for oncology.
- AI solutions integrated with imaging devices for automated analysis.
- Machine learning tools for predicting cancer treatment response from images.
- Deep learning applications for radiation oncology planning based on imaging.
Exclusions
- General AI solutions in healthcare not specifically for oncology.
- Non-imaging AI applications in oncology, such as genomics or drug discovery AI.
- Traditional medical imaging equipment without integrated AI capabilities.
- AI for non-cancerous conditions or general diagnostic radiology.
- Standalone Picture Archiving and Communication Systems (PACS) without AI functionalities.
Market Size Forecast
Executive Summary
• The AI Oncology Imaging market is valued at $600.0 Mn in 2025 and is forecast to reach $3.4 Bn by 2035, reflecting a robust CAGR of 18.9% as demand accelerates across every major segment and region over the ten-year outlook.
• AI-powered Computer-Aided Detection (CADe) leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• Asia Pacific commands the largest regional share at XX.X%.
• United States remains the single largest country-level market at XX.X% of global share, anchoring overall demand within its home region throughout the forecast period.
• Consolidation intensifies as major medical imaging players acquire specialized AI developers, integrating advanced algorithms and securing data access, fundamentally reshaping the competitive landscape and driving ecosystem verticalization across oncology pathways.
• Clinical validation and proven ROI in improving diagnostic accuracy and physician workflow efficiency remain critical catalysts, accelerating widespread adoption and driving demand for integrated AI solutions across diverse oncology care settings globally.
• Regulatory harmonization and the increasing sophistication of multi-modal AI models, including federated learning capabilities, are pivotal for overcoming data silos and enabling comprehensive, patient-centric cancer management solutions across jurisdictions.
• Developed markets prioritize AI for precision treatment planning and early detection, while emerging economies focus on basic diagnostic augmentation and accessibility, creating distinct regional strategic imperatives for market penetration and product development.
• Significant venture capital investment targets novel AI platforms for prognosis and recurrence prediction, yet successful hospital integration necessitates robust IT infrastructure and comprehensive clinician training to realize full operational benefits.
• The market's future hinges on seamless integration of AI-powered imaging with genomics and pathology, enabling true precision oncology by personalizing treatment trajectories and optimizing patient outcomes from initial diagnosis.
Key Market Takeaways
Critical findings and data points from this market research study.
Current Market Valuation
The AI Oncology Imaging Market is valued at $600.0 million in the base year, indicating its foundational presence in medical diagnostics.
Future Market Projection
This market is projected for substantial growth, reaching $3.4 billion by the forecast year, reflecting strong anticipated adoption.
Exceptional Growth Rate
An impressive Compound Annual Growth Rate (CAGR) of 18.9% is expected, highlighting the rapid expansion and increasing importance of AI in oncology imaging.
Significant Market Expansion
The market demonstrates significant expansion potential, growing from $600.0 million to $3.4 billion, underscoring the transformative impact of AI in cancer care.
AI Integration Drives Growth
Increasing integration of artificial intelligence solutions into oncology imaging workflows is a primary driver, revolutionizing diagnostic capabilities across healthcare settings.
Precision Diagnostics Trend
A notable trend fueling market growth is the escalating demand for enhanced accuracy, efficiency, and personalized treatment planning in cancer detection and management through AI.
Market Dynamics
Market Trends
- Increasing integration of AI tools into routine radiology workflows.
- Growing demand for explainable AI to build clinician trust and adoption.
- Emergence of multi-modal AI combining various imaging and clinical data.
- Stronger focus on AI for personalized cancer diagnosis and treatment planning.
Growth Drivers
- Rising global cancer incidence drives demand for early, precise diagnosis.
- Radiologist shortages prompt AI adoption for improved efficiency and accuracy.
- Continuous advancements in AI algorithms and computing power fuel innovation.
- Increasing investments and government funding for digital health technologies.
Restraints
- Stringent regulatory approval processes delay market entry and product adoption.
- Limited availability of diverse, high-quality, annotated oncology imaging datasets.
- Challenges in seamlessly integrating AI solutions into existing clinical workflows.
- Hesitancy among medical professionals to fully trust AI-driven diagnostic tools.
Opportunities
- Significant untapped potential in expanding AI solutions to emerging economies.
- Developing specialized AI for early detection of rare or aggressive cancers.
- AI for predictive analytics in treatment response and recurrence monitoring.
- Seamless integration of AI with existing hospital information systems (EHR/PACS).
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | AI-Powered Computer-Aided DetectionAI-Powered Computer-Aided DiagnosisAI-Powered Prognosis and PredictionAI-Powered Treatment Planning & Response AssessmentAI-Powered Workflow & Image ManagementAI-Powered Image Reconstruction & EnhancementAI-Driven Drug Discovery & Biomarker IdentificationAI-Powered Medical Device Integration Software |
| By Technology | Deep LearningMachine LearningNatural Language ProcessingComputer VisionPredictive AnalyticsReinforcement LearningGenerative AI |
| By Application | Breast CancerLung CancerProstate CancerColorectal CancerBrain CancerLiver CancerHead & Neck CancerOther Cancers |
| By End-User | HospitalsDiagnostic Imaging CentersCancer Research CentersPharmaceutical & Biotechnology CompaniesAcademic & Research InstitutesSpecialty ClinicsContract Research Organizations |
| By Deployment | On-PremiseCloud-BasedHybridEdge Computing |
| By Imaging Modality | Computed TomographyMagnetic Resonance ImagingPositron Emission TomographyUltrasoundX-RayMammographyDigital PathologySingle-Photon Emission Computed Tomography |
Regional Analysis
- North America dominates the AI Oncology Imaging market due to its advanced healthcare infrastructure, significant R&D investments, and rapid adoption of innovative technologies. High prevalence of cancer and a strong presence of key industry players further solidify its leading position in medical device integration.
- Asia-Pacific is the fastest-growing region for AI Oncology Imaging, driven by rapidly improving healthcare infrastructure and substantial government investments in digital health. Rising cancer prevalence and growing demand for early, precise diagnostics in economies like China and India propel this accelerated market expansion.
- Europe is witnessing a significant trend towards stringent regulatory frameworks for AI in oncology imaging, notably influenced by the EU AI Act. This emphasis on data privacy, ethical AI, and standardized validation processes is shaping product innovation and market entry across European Union countries.
| Asia PacificXX.X% | North AmericaXX.X% | EuropeXX.X% | Latin AmericaXX.X% | Middle East & AfricaXX.X% |
North America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- A mature yet highly innovative market, North America leads in R&D and early adoption of cutting-edge AI technologies for oncology imaging, supported by significant private investment, established healthcare infrastructure, and favorable regulatory pathways.
Latin America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- This region represents a developing market for AI oncology imaging, marked by increasing healthcare investments and a growing awareness of AI's benefits, though adoption rates vary significantly across countries due to economic disparities and infrastructure challenges.
Europe
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Characterized by strong public healthcare systems and a growing focus on digital health, Europe demonstrates steady adoption of AI oncology imaging, with ongoing efforts to standardize regulations and foster cross-border collaboration in research and clinical implementation.
Asia Pacific
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Driven by massive patient populations, increasing healthcare expenditure, and robust government initiatives, particularly in China and India, this region is witnessing rapid adoption of AI oncology imaging solutions, fostering local innovation and strategic partnerships.
Middle East & Africa
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- The market here is highly diverse, with significant investments in advanced medical technologies in GCC countries driving rapid adoption, while other sub-regions face hurdles like limited infrastructure and funding, leading to a fragmented but growing landscape.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | US$ XX.X Mn | XX.X% | Leading the market due to significant R&D investment, high adoption of advanced medical technologies, and a large patient base. Strong regulatory support and a robust ecosystem for AI innovation further drive its growth in oncology imaging. |
| 2 | Brazil | US$ XX.X Mn | XX.X% | The largest healthcare market in South America, demonstrating growing adoption of digital health solutions and increasing investment in medical technology. Its large population and rising cancer incidence drive the demand for advanced AI oncology imaging. |
| 3 | Germany | US$ XX.X Mn | XX.X% | A frontrunner in medical technology and research, with a robust healthcare system and significant investments in precision medicine and digital health. High-quality clinical data and strong industry-academia collaborations fuel its AI oncology imaging market. |
| 4 | China | US$ XX.X Mn | XX.X% | Dominates the APAC market due to a vast patient population, aggressive government support for AI and healthcare innovation, and rapid digital infrastructure expansion. Its focus on early cancer screening and diagnosis is a major driver for AI oncology imaging. |
| 5 | Saudi Arabia | US$ XX.X Mn | XX.X% | Undergoing significant healthcare transformation as part of Vision 2030, with substantial government investment in advanced medical infrastructure and digital health. High cancer incidence rates and a focus on early detection drive the adoption of AI oncology imaging. |
Countries Covered (26)
United States, Canada, Mexico, Brazil, Argentina, Rest of Latin America, Germany, United Kingdom, France, Italy, Spain, Russia, Rest of Europe, China, Japan, India, South Korea, Australia, Taiwan, Singapore, Malaysia, Rest of Asia Pacific, Saudi Arabia, United Arab Emirates, South Africa, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | Paige.AI | XX.X% | Focus on developing AI-powered diagnostic solutions for pathology to aid cancer diagnosis and prognosis. | — | — | Paige Prostate DetectPaige Breast DetectPaige Gastric Detect+1 |
| 2 | Lunit | XX.X% | Develop AI solutions for precision diagnostics and therapeutics, covering both imaging and pathology. | — | — | Lunit INSIGHT MMGLunit INSIGHT CXRLunit SCOPE IO+1 |
| 3 | Aidoc | XX.X% | Provide AI solutions that triage and flag critical findings in medical images, accelerating radiologist workflow. | — | — | Aidoc aiWorklistAidoc BrainAidoc Pulmonary Embolism+1 |
| 4 | PathAI | XX.X% | Leverage AI and machine learning to improve the accuracy and efficiency of pathology diagnosis and accelerate drug development. | — | — | PathAI Dx platformAISightClinician Insights+1 |
| 5 | Ibex Medical Analytics | XX.X% | Develop AI-powered cancer diagnostics in pathology to assist pathologists in improving accuracy and efficiency. | — | — | Galen ProstateGalen BreastGalen Gastric+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
Paige.AI, Lunit, Aidoc, PathAI, Ibex Medical Analytics, Qure.ai, Volpara Health Technologies, Nanox Imaging, Elekta, ScreenPoint Medical, Vuno, Aidence, Proscia, Accuray, Therapixel, Riverain Technologies, Beijing Infervision Technology, DeepMotion Medical, Imagen Technologies, Viz.ai
The global AI Oncology Imaging market features a competitive landscape led by Paige.AI, Lunit, Aidoc, PathAI, Ibex Medical Analytics, and Qure.ai, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on company revenue disclosures and public sources; undisclosed figures are marked.
Company Profiles
Paige.AI
Lunit
Aidoc
PathAI
Ibex Medical Analytics
Qure.ai
Volpara Health Technologies
Nanox Imaging
Elekta
ScreenPoint Medical
Vuno
Aidence
Proscia
Accuray
Therapixel
Riverain Technologies
Beijing Infervision Technology
DeepMotion Medical
Imagen Technologies
Viz.ai
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
AI-Powered Prostate Cancer Detection Tool Gains FDA Clearance
A prominent AI medical imaging company announced FDA clearance for its novel AI software, designed to enhance the accuracy and efficiency of prostate cancer detection on MRI scans, promising to reduce radiologist workload and improve diagnostic consistency.
Major Hospital Network Adopts AI for Lung Cancer Screening
A leading AI oncology imaging firm partnered with a national hospital network to integrate its AI-powered lung nodule detection software across multiple imaging centers. This collaboration aims to significantly improve early detection rates for lung cancer patients nationwide.
AI Oncology Imaging Innovator Secures US$ XX.X Series C Funding
An emerging leader in AI-driven personalized cancer treatment planning announced a successful US$ XX.X Series C funding round. The substantial capital will fuel further research and development, alongside commercial expansion of its predictive imaging analytics platform.
Health Tech Giant Acquires Leading AI Radiomics Firm
A major health technology conglomerate acquired a prominent AI company specializing in radiomics for cancer prognostication. This strategic move aims to integrate advanced predictive analytics into its comprehensive oncology solutions portfolio, enhancing treatment stratification capabilities.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $600.0 Mn |
| Market Size (Forecast) | $3.4 Bn |
| CAGR | 18.9% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 26 Countries |
| Segments Covered | 6 Segments, 42 Sub-segments |
| Companies Profiled | 32 Companies |
Report Value
Why Choose This Report
Complete Market Size
Market sizing for the base year and a 10-year forecast across three scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data for every country in the report scope, across all major regions.
Company Profiles
Profiles of the leading companies, with disclosed financials, strategy and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Strategic Analysis · Management Insights · CXO Insights
Executive Strategic & Intelligence Report
A board-ready strategic deck built on the AI Oncology Imaging Market report: eleven chapters and an appendix, from market sizing to the board decisions, delivered as a PDF with an Excel datapack. US$3,000 per market, prepared after your order.
What to expect in the Executive Report for this market
- About 400 slides, 11 chapters and an appendix. Built on this report's own numbers, so every figure matches the report and the Excel.
- Market size and forecast to 2035. By segment, sub-segment, region and country, with conservative, base and optimistic cases.
- An analysis page after every exhibit. The key insight, ten specific points and the decision it implies for leaders, challengers, entrants and investors.
- Competitive intelligence. Shares and positioning, capability benchmark, strategies, recent moves and acquisition screening.
- Customers, technology and business models. Who buys and why, AI and technology impact, pricing, channels and go-to-market by segment.
- Risks and scenarios. Risk register, four future scenarios with signposts, and early-warning indicators with thresholds.
- Opportunities and the board decisions. Opportunity scoring, strategic options, roadmap, capability gaps, decision matrix and a 90-day plan.
- PDF, Excel datapack and PowerPoint. A bookmarked PDF, the full Excel datapack and editable infographic slides for your own decks.
US$3,000 per market · bought online, prepared after your order and emailed to you
See a full example report →Only need the headline view? Market Snapshot (PDF) + Excel Datasheet · 10–20 slide PDF + Excel
A CEO-level executive summary of the market in 10–20 slides - size and forecast, growth by segment and region, the leading countries and companies, key trends and the outlook - plus the Excel datasheet. A short executive view of this market, not the full analysis - PDF and Excel, prepared and emailed to you after your order.
Trusted by strategy teams, investors & global enterprises
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
VP, Corporate Strategy
Industrial manufacturing company
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Director, Investment Research
Private equity firm
“We now use these reports in every planning cycle. The regional granularity, and the same numbers across the report, the dashboard and the Excel, save our team real time.”
Head of Market Intelligence
Specialty chemicals company
Frequently Asked Questions
Common questions about this report and our research
The AI Oncology Imaging market is estimated at $600.0 Mn in 2025. It is forecast to reach $3.4 Bn in 2035.
The AI Oncology Imaging market is forecast to grow at a CAGR of 18.9% from 2025 to 2035.
The main segments are by Type, Technology, Application, End-User, Deployment, and Imaging Modality. Key applications include Breast Cancer, Lung Cancer, and Prostate Cancer.
Leading companies include Paige.AI, Lunit, Aidoc, PathAI, Ibex Medical Analytics, Qure.ai, Volpara Health Technologies, Nanox Imaging, Elekta, ScreenPoint Medical, Vuno, and Aidence.
The report covers market size and growth, segmentation by Type, Technology, Application, End-User, Deployment, and Imaging Modality, and regional analysis. It also includes market trends, drivers, restraints, and opportunities.
The Single User and Enterprise licences include the full PDF report, the PowerPoint (PPT), the Excel data workbook and the interactive Online Dashboard. The Online Dashboard gives online access to the snapshot and datasheet with export features, and the Market Snapshot is an executive summary in PDF with the Excel data sheet.
Yes. Request a free report preview: its scope, every chapter and what it contains, the methodology and the headline figures. The full report is a paid product.
We accept credit/debit cards (Visa, Mastercard, Amex), bank wire transfer, and purchase orders for enterprise clients. All transactions are secured with 256-bit SSL encryption.
Buy This Report
Choose the format that fits your budget
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
Strategic deck for this market
Executive Strategic & Intelligence Report
About 400 board-ready slides: every exhibit with its analysis and the decision it implies. Prepared for this market after your order and emailed to you.
Need to go deeper?
Intelligence services for this market
- Competitor benchmarking →
- Market entry & expansion →
- Product & growth opportunities →
- Investment & acquisition due diligence →
What's Included
Similar Reports
AI Medical Imaging Market
$3.3 Bn in 2025 · 16.8% CAGR
AI Organ Imaging Market
$584.0 Mn in 2025 · 17.0% CAGR
Future Medical Imaging Market
$52.4 Bn in 2025 · 5.9% CAGR
Musculoskeletal Imaging Market
$4.8 Bn in 2025 · 5.8% CAGR
Nuclear Imaging Market
$3.1 Bn in 2025 · 4.7% CAGR
Portable Imaging Market
$2.9 Bn in 2025 · 5.8% CAGR
Retinal Imaging Market
$2.5 Bn in 2025 · 10.2% CAGR
Structural Heart Imaging Market
$1.1 Bn in 2025 · 7.2% CAGR